BACKGROUND. Sarcopenia is commonly assessed on CT by use of the skeletal muscle
index (SMI), which is calculated as the skeletal muscle area (SMA) at L3 divided by patient …

Background A growing body of evidence has demonstrated the prognostic value of skeletal
muscle area and quality measured by computed tomography (CT) as biomarkers of …

Measurements of skeletal muscle cross-sectional area (SMA) at the level of the third lumbar
(L3) vertebra derived from clinical computed tomography (CT) scans are commonly used in …

Background Loss of muscle mass is a known feature of sarcopenia and predicts poor clinical
outcomes. Although muscle metrics can be derived from routine computed tomography (CT) …

Objective: Until now, cutoff values of low skeletal muscle mass using computed tomography
(CT) were driven by optimal stratification to predict mortality in cancer patients. The aim of …

Background We aimed to evaluate the feasibility of the upper thigh level as a landmark to
measure muscle area for sarcopenia assessment on computed tomography (CT). Methods …

Various methods were suggested to measure skeletal muscle areas (SMAs) using chest low-
dose computed tomography (chest LDCT) as a substitute for SMA at 3rd lumbar vertebra …

Background Skeletal muscle mass is an essential parameter for diagnosing sarcopenia. The
gold standard for assessing skeletal muscle mass is using computed tomography (CT) to …

Background Although computed tomography (CT) is considered the gold standard for
investigating skeletal muscles, diagnostic cutoff points for sarcopenia have not been …

Background Quantification of abdominal muscle mass by cross-sectional imaging has been
increasingly used to diagnose sarcopenia; however, the technical method for quantification …